维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="DUGI KA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately con- trolled by a combination of metformin and sulphonylurea: a 24 week randomized study 显示文摘	Owens DR Swallow R Dugi KA	2011	Diabet Med2011，28，11：	1
2	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study显示文摘	Owens DR Swallow R Dugi KA	2011	Diabet Med2011，28，11：	1
3	The endothelium and lipoproteins:insights from recent cell biology and animal studies显示文摘	Dader DJ Dugi KA	2000	Semin Thromb Hemost2000，26，5：	1
4	显示文摘	Dugi KA Brandaur N Schmidt B	2001	Circulation2001，104，：	1
5	Structure, function and role of lipoprotein lipase in lipoprotein metabolism 显示文摘	Santamarina-FS Dugi KA	1994	Curt Opin Lipidol1994，5，2：	1
6	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study显示文摘	OWENS DR SWALLOW R DUGI KA et ol	2011	Diabet Med2011，28，11：	1
7	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea:a24-week randomized study显示文摘	OWENS DR SWALLOW R DUGI KA	2011	Diabet Med2011，28，13：	1
8	Low hepatic lipase ac- tivity is a novel risk factor for coronary artery disease显示文摘	Dugi KA Brandauer K Schmidt N	2001	Circu?lation2001，104，30：	1
9	Structure,function and role of lipoprotein lipase in lipoprotein metabolism显示文摘	SantamarinaFoj o S Dugi KA	1994	Curr Oping Lipodol1994，5，：	1
10	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of mefformin and sulphonylurea: a 24-week randomized study显示文摘	OWENS DR SWALLOW R DUGI KA	2011	Diabet Med2011，28，11：	1
11	Activity and concentration of lipoprotein lipase in postheparin plasma and the extent of coronary artery disease 显示文摘	Dugi KA Schmidt N Brandauer K	2002	Atheroselerosis2002，163，2：	1
12	Efficacy and safety of linagliptin in persons with type 2 diabetes in- adequately controlled by a combination of metformin and sulphonylurea : a 24-week randomized study 显示文摘	Owens DR Swallow R Dugi KA	2011	Diabet Med2011，28，11：	1
13	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea:a 24-week randomized study显示文摘	Owens DR Swallow R Dugi KA		0，，：	1
14	Structure,function and role of lipoprotein lipase in lipoprotein metabolism显示文摘	Santamarina-Fojo S Dugi KA	1994	Curr Opin Lipidol1994，5，2：	1
15	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study 显示文摘	Owens DR Swallow R Dugi KA	2011	Diabet Med2011，28，11：	1
16	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulpbonylurea:a 24 week randomized study显示文摘	Owens DR Swallow R Dugi KA	2011	Diabet Med2011，28，11：	1
17	Low hepatic lipase activity is a novel risk factor for coronary artery disease显示文摘	Dugi KA Brandauer K Schmidt N	2001	Circulation2001，104，：	1
18	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study显示文摘	Owens DR Swallow R Dugi KA	2011	Diabet Med2011，28，：	1
19	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea:a 24-week randomized study(1)显示文摘	Owens DR Swallow R Dugi KA		Diabetic Medicine0，，：	1
20	In vivo evidence for both lipolytic and nonlipolytic function for hepatic lipase in the metabolism of HDL 显示文摘	Dugi KA Amar JM Haudenschild CC	2000	Arterioscler Thromb Vasc Biol2000，20，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示